FDA warning letter · Drugs

Pharmacy Plus, Inc., dba Vital Care Compounder

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Your firm did not take appropriate corrective action after microbial contamination was recovered within the ISO 5 aseptic processing area.

Passage 2

Your firm failed to perform adequate smoke studies under dynamic conditions to demonstrate unidirectional airflow within the ISO 5 area. Therefore, your products intended to be sterile are produced in an environment that may not provide adequate protection against the risk of contamination.